21 related articles for article (PubMed ID: 7719460)
1. Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women.
Frost CE; Adams J; Shelton M; Ebid AH; Gugino LJ; Hewitt R; Difrancesco R; Ingalls E; Cousins S; Hu J; Morse GD
Clin Drug Investig; 2002; 22(2):125-34. PubMed ID: 23315400
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.
Ghosn J; De Montgolfier I; Cornélie C; Dominguez S; Pérot C; Peytavin G; Marcelin AG; Pauchard M; Ouagari Z; Bonmarchand M; Agher R; Calvez V; Bricaire F; Dommergues M; Katlama C; Tubiana R
Antimicrob Agents Chemother; 2008 Apr; 52(4):1542-4. PubMed ID: 18250187
[TBL] [Abstract][Full Text] [Related]
3. Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire.
Danel C; Moh R; Peytavin G; Anzian A; Minga A; Gomis OB; Seri B; Nzunettu G; Gabillard D; Salamon R; Bissagnene E; Anglaret X
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):62-6. PubMed ID: 17263634
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir.
Sadler BM; Gillotin C; Lou Y; Eron JJ; Lang W; Haubrich R; Stein DS
Antimicrob Agents Chemother; 2001 Dec; 45(12):3663-8. PubMed ID: 11709366
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of antiviral activity and intracellular pharmacokinetics of human immunodeficiency virus type 1 protease inhibitors in tissue culture.
Nascimbeni M; Lamotte C; Peytavin G; Farinotti R; Clavel F
Antimicrob Agents Chemother; 1999 Nov; 43(11):2629-34. PubMed ID: 10543739
[TBL] [Abstract][Full Text] [Related]
6. Single-dose pharmacokinetics of indinavir and the effect of food.
Yeh KC; Deutsch PJ; Haddix H; Hesney M; Hoagland V; Ju WD; Justice SJ; Osborne B; Sterrett AT; Stone JA; Woolf E; Waldman S
Antimicrob Agents Chemother; 1998 Feb; 42(2):332-8. PubMed ID: 9527781
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.
De Wit S; Debier M; De Smet M; McCrea J; Stone J; Carides A; Matthews C; Deutsch P; Clumeck N
Antimicrob Agents Chemother; 1998 Feb; 42(2):223-7. PubMed ID: 9527763
[TBL] [Abstract][Full Text] [Related]
8. Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching.
Woolf E; Au T; Haddix H; Matuszewski B
J Chromatogr A; 1995 Feb; 692(1-2):45-52. PubMed ID: 7719460
[TBL] [Abstract][Full Text] [Related]
9. Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection.
Giraud E; Rey E; Tréluyer JM; Pons G; Jullien V
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):86-90. PubMed ID: 16260190
[TBL] [Abstract][Full Text] [Related]
10. Determination of L-756 423, a novel HIV protease inhibitor, in human plasma and urine using high-performance liquid chromatography with fluorescence detection.
Rose MJ; Merschman SA; Woolf EJ; Matuszewski BK
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):425-35. PubMed ID: 10517365
[TBL] [Abstract][Full Text] [Related]
11. Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography.
Cateau E; Tournier N; Dupuis A; Le Moal G; Venisse N
J Pharm Biomed Anal; 2005 Sep; 39(3-4):791-5. PubMed ID: 15927437
[TBL] [Abstract][Full Text] [Related]
12. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
Colombo S; Guignard N; Marzolini C; Telenti A; Biollaz J; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):25-34. PubMed ID: 15358304
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of unlabeled and deuterium-labeled indinavir in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection.
Woolf EJ; Matuszewski BK
J Pharm Sci; 1997 Feb; 86(2):193-8. PubMed ID: 9040094
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
